Literature DB >> 22847229

Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice.

Kumar Venkatesan1, Philippe Alix, Alice Marquet, Melissa Doupagne, Isabelle Niespodziany, Bernard Rogister, Vincent Seutin.   

Abstract

Synaptic vesicle protein 2 (SV2) is a glycoprotein that exists in three isoforms, SV2A, SV2B, and SV2C. SV2A knockout (KO) mice and SV2A/SV2B double KO (DKO) mice, but not SV2B KO animals, start to experience severe seizures and weight loss 7 days after birth and die at about postnatal day (P)14-P23. Because excitatory and inhibitory inputs play a major role in controlling neuronal excitability in the hippocampus, we examined the effects of SV2A and/or SV2B deletions on glutamatergic and GABA(A) neurotransmission in hippocampal CA1 pyramidal neurons. Spontaneous and miniature excitatory and inhibitory postsynaptic currents (sEPSCs, mEPSCs, sIPSCs, and mIPSCs, respectively) were recorded using the whole-cell patch-clamp technique in slices from P6-P14 mice. The frequency of sEPSCs was increased in SV2A KO and SV2A/SV2B DKO mice, but their amplitude was unchanged. Such changes were not observed in SV2B KOs. On the contrary, the frequency and amplitude of sIPSCs were decreased in SV2A KO and SV2A/SV2B DKO mice but not in SV2B KO animals, as reported previously for the CA3 region. Kinetic parameters of sIPSCs and sEPSCs were unchanged. Importantly, no changes were observed in any genotype when examining mEPSCs and mIPSCs. We conclude that action potential- and Ca(2+) -dependent glutamatergic and GABAergic synaptic transmission are differentially altered in the hippocampus of SV2A-deficient mice, whereas the mechanism of exocytosis itself is not changed. The altered balance between these major excitatory and inhibitory inputs is probably a contributing factor to seizures in SV2A KO and SV2A/SV2B DKO mice.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22847229     DOI: 10.1002/jnr.23111

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

1.  Hypertension-induced synapse loss and impairment in synaptic plasticity in the mouse hippocampus mimics the aging phenotype: implications for the pathogenesis of vascular cognitive impairment.

Authors:  Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Stefano Tarantini; Andriy Yabluchanskiy; Gábor Fülöp; Tripti Gautam; Albert Orock; Anna Csiszar; Ferenc Deak; Zoltan Ungvari
Journal:  Geroscience       Date:  2017-06-29       Impact factor: 7.713

Review 2.  Synaptic vesicle protein 2: A multi-faceted regulator of secretion.

Authors:  Kristine Ciruelas; Daniele Marcotulli; Sandra M Bajjalieh
Journal:  Semin Cell Dev Biol       Date:  2019-03-21       Impact factor: 7.727

3.  Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes.

Authors:  Sara Sanz-Blasco; Juan C Piña-Crespo; Xiaofei Zhang; Scott R McKercher; Stuart A Lipton
Journal:  Neuroreport       Date:  2016-06-15       Impact factor: 1.837

4.  Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment.

Authors:  Itzel Jatziri Contreras-García; Gisela Gómez-Lira; Bryan Víctor Phillips-Farfán; Luz Adriana Pichardo-Macías; Mercedes Edna García-Cruz; Juan Luis Chávez-Pacheco; Julieta G Mendoza-Torreblanca
Journal:  Brain Sci       Date:  2021-04-23

5.  Overlapping functions of stonin 2 and SV2 in sorting of the calcium sensor synaptotagmin 1 to synaptic vesicles.

Authors:  Natalie Kaempf; Gaga Kochlamazashvili; Dmytro Puchkov; Tanja Maritzen; Sandra M Bajjalieh; Natalia L Kononenko; Volker Haucke
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

6.  Development and Validation of a New Mouse Model to Investigate the Role of SV2A in Epilepsy.

Authors:  Catherine Menten-Dedoyart; Maria Elisa Serrano Navacerrada; Odile Bartholome; Judit Sánchez Gil; Virginie Neirinckx; Sabine Wislet; Guillaume Becker; Alain Plenevaux; Priscilla Van den Ackerveken; Bernard Rogister
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

7.  Levetiracetam Affects Differentially Presynaptic Proteins in Rat Cerebral Cortex.

Authors:  Daniele Marcotulli; Giorgia Fattorini; Luca Bragina; Jessica Perugini; Fiorenzo Conti
Journal:  Front Cell Neurosci       Date:  2017-12-11       Impact factor: 5.505

Review 8.  Puzzling Out Synaptic Vesicle 2 Family Members Functions.

Authors:  Odile Bartholome; Priscilla Van den Ackerveken; Judit Sánchez Gil; Orianne de la Brassinne Bonardeaux; Pierre Leprince; Rachelle Franzen; Bernard Rogister
Journal:  Front Mol Neurosci       Date:  2017-05-22       Impact factor: 5.639

9.  Expression of SV2 isoforms during rodent brain development.

Authors:  Julie Crèvecœur; Patrik Foerch; Melissa Doupagne; Caroline Thielen; Catherine Vandenplas; Gustave Moonen; Manuel Deprez; Bernard Rogister
Journal:  BMC Neurosci       Date:  2013-08-09       Impact factor: 3.288

Review 10.  Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond.

Authors:  Wolfgang Löscher; Michel Gillard; Zara A Sands; Rafal M Kaminski; Henrik Klitgaard
Journal:  CNS Drugs       Date:  2016-11       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.